With pharma exiting Alzheimer’s research, new hope (and urgency) seen in the combination of brain training and transcranial direct current stimulation (tDCS)

By SharpBrains | January 22, 2018

___ What does the future hold for the war on Alzheimer’s? (The Globe and Mail): “After spend­ing huge sums on clin­i­cal trails in recent years, the phar­ma­ceu­ti­cal indus­try has failed to find a drug that can halt the mind-rob­bing dis­ease. And this month, Pfiz­er announced it is end­ing its Alzheimer’s research, although oth­er com­pa­nies haven’t thrown…

Read More

Explore the latest in cognitive remediation and addressing learning disabilities

By SharpBrains | January 11, 2017

Expo Day: Hap­py Neu­ron and Arrow­smith Pro­gram from Sharp­Brains Dur­ing Expo Day select­ed Sum­mit Part­ners and Spon­sors show­cased their lat­est ini­tia­tives and solu­tions. Franck Tarpin-Bernard, Man­ag­ing Direc­tor of Sci­en­tif­ic Brain Train­ing (SBT), dis­cussed new part­ner­ships fol­low­ing their ISO 13485 cer­ti­fi­ca­tion for med­ical devices — cog­ni­tive reme­di­a­tion. Jes­si­ca Poulin, Strate­gic Oper­a­tions Man­ag­er at the Arrow­smith Program,…

Read More

Update: 20 Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

By SharpBrains | June 30, 2016

—– Time for a new edi­tion of Sharp­Brains’ e‑newsletter,  pro­vid­ing a win­dow into the ongo­ing brain health and neu­ro­plas­tic­i­ty revolutions–plus some fun brain teasers. Hap­py read­ing and, for those of you in the USA, Hap­py Fourth of July, and for those of you in Cana­da, Hap­py Cana­da Day! New research: 20 Must-Know Facts to Har­ness Neu­ro­plas­tic­i­ty and…

Read More

Merck and HAPPYneuron partner to include cognitive remediation program in Multiple Sclerosis e‑Health Solution

By SharpBrains | June 13, 2016

Mer­ck KGaA In Deal With HAP­PYneu­ron To Offer E‑Health Solu­tion For MS Patients (Nas­daq): “Ger­man drug mak­er Mer­ck KGaA (MKGAY.PK) announced Mon­day that it has entered into an agree­ment with HAP­PYneu­ron, a sub­sidiary of SBT Group of France, in which Mer­ck will receive an exclu­sive license to the com­pa­ny’s cog­ni­tive reme­di­a­tion train­ing pro­gram for people…

Read More

Next: Scalable, medication-free relief of cognitive symptoms related to Multiple Sclerosis (MS)

By SharpBrains | April 29, 2016

———- At-Home Cog­ni­tive Reme­di­a­tion May Pro­vide Med­i­ca­­tion-Free Symp­tom Relief for Neu­ropsy­cho­log­i­cal Issues Asso­ci­at­ed with Mul­ti­ple Scle­ro­sis (press release): “Cog­ni­tive impair­ment is one of the core symp­toms of mul­ti­ple scle­ro­sis (MS)—and one of its most trou­bling con­cerns for many peo­ple with the con­di­tion. Now, a new study from NYU Lan­gone Med­ical Cen­ter may pro­vide hope for…

Read More

Research series: How, when and why does targeted cognitive training work to promote behavioral and emotional health?

By SharpBrains | February 2, 2015

. Explor­ing Tar­get­ed Cog­ni­tive Train­ing for Clin­i­cal Dis­or­ders (Asso­ci­a­tion for Psy­cho­log­i­cal Sci­ence): “Research on the treat­ment of men­tal dis­or­ders often cen­ters on under­stand­ing which treat­ments work. But know­ing that a treat­ment is effec­tive doesn’t nec­es­sar­i­ly tell us why the treat­ment works. A bet­ter under­stand­ing of the pre­cise mech­a­nisms that 

Read More